9.050
+0,00%
2026-10-19
Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +180.3% | +145.0% | 3 / 3 | +45.9% | +2.42 pp | +4.19 pp | +12.1% | 0.43 | 5.54 | 268 | +45,9% | 23,4 | +180,3% | 5.54 | 10.95 | −49,4% |
| Pts | 12 | 12 | 12 | 12 | 8 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 9.050 (close price on 2026-10-19)EPS (TTM): 1.633
Financial charts
1.Revenue & growth
VND bn268Q2/26
1.Revenue & growth
VND bn268Q2/26
2.Profit & growth
VND bn23,4Q2/26
3.Profit mix (Penman)
VND bn51,1Q2/26
4.Margins & cost structure
%11.2%Q2/26
5.Returns & cash cycle
% · days11.7%Q2/26
6.Earnings quality & cash
VND bn83,5Q2/26
7.Asset structure
VND bn601Q2/26
8.Funding & debt health
VND bn · times601Q2/26
9.Revenue backlog
VND bn10,6Q2/26
10.Valuation
times · %5,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %941Q2/26
Adjusted EPS growth, latest quarter
180%
Average adjusted EPS growth, 3 quarters
137%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26